Results of Placing and Retail Offer

RNS Number : 8261Q
SigmaRoc PLC
23 February 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN SIGMAROC PLC OR ANY OTHER ENTITY IN ANY SUCH JURISDICTION.

 

 23 February 2023

(EPIC: SRC / Market: AIM / Sector: Construction Materials)

 

SIGMAROC PLC

    ( ' SigmaRoc ', the 'Group'  or the 'Company')

Results of Placing and REX Retail Offer

 

SigmaRoc (AIM: SRC), the quarried materials group, is pleased to announce the successful completion of the Placing and REX Retail Offer announced yesterday by the Company (the "Placing Announcement"), raising gross proceeds of approximately £30 million.

 

The Company has placed, in aggregate, 55,555,555 new Ordinary Shares pursuant to the Fundraising, each at a price of 54 pence per share, representing a premium of approximately 1.8 per cent. to the mid-market closing price of 53 pence on 22 February 2023 .

 

The Company consulted with and received strong support from many of its largest shareholders prior to the Fundraising. Consistent with each of its prior placings, the Company respected the principles of pre-emption, so far as possible, through the allocation process, both in the Placing and the Retail Offer. The Company's management team actively participated in the structuring and allocation of the Fundraising.

 

The proceeds of the Fundraising will part fund ten potential near term strategic acquisition opportunities and four organic growth and carbon footprint reduction projects. Taken together, the Acquisitions and Organic Investment Projects are anticipated, should they all complete, to generate approximately £42 million of net revenue, £10 million of EBITDA and profit after tax of £6 million on an annualised basis.

 

Director participation

 

Certain Directors and senior management of SigmaRoc have subscribed, in aggregate, for 455,556 Placing Shares at the Placing Price and the table below sets out each individual's allocation:

 

Name

No. Ordinary Shares currently held

Placing Shares subscribed for

Holding following Admission

% of issued share capital after Admission

David Barrett

  3,053,439

  265,741

  3,319,180

0.48%

Max Vermorken

  762,219

  64,815

  827,034

0.12%

Garth Palmer

  616,146

  55,556

  671,702

0.10%

Charles Trigg

  344,830

  37,037

  381,867

0.06%

Fons Vermorken

  266,884

  23,148

  290,032

0.04%

Dean Masefield

  78,868

  9,259

  88,127

0.01%

 

Max Vermorken, CEO of SigmaRoc, commented on the Fundraising as follows:

 

"I am pleased to see many of our existing shareholders continuing to support SigmaRoc and our buy-and-build strategy. The strong level of demand from new and existing investors underpins confidence in our plans for the future.

 

We have identified a strong pipeline of acquisitions as well as organic growth opportunities that this funding will help us to deliver and we look forward to updating our shareholders on our progress in due course."

 

 

Settlement and dealings

 

Application has been made to the London Stock Exchange for the Fundraising Shares to be admitted to trading on AIM.

 

Admission is expected to take place, and dealings are expected to commence at 08.00 a.m. on 28 February 2023.

 

Total voting rights

 

In accordance with the provision of the Disclosure Guidance and Transparency Rules of the FCA ('DTRs'), the Company confirms that, following Admission, its issued share capital will comprise 693,801,899 Ordinary Shares.  The Company does not hold any Ordinary Shares in treasury.  Therefore, the total voting rights in the Company will be 693,801,899.  This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the DTRs.

 

The Fundraising Shares will, following Admission, rank pari passu in all respects with the existing Ordinary Shares.

 

 

Capitalised terms used in this announcement, unless otherwise defined herein, have the same meaning as ascribed to them in the Placing Announcement.

 

 

For further information, please contact:

 

SigmaRoc plc

Max Vermorken

 

Tel: +44 (0) 207 129 7828

Liberum Capital (Nomad and Joint Bookrunner)

Nicholas How / Ben Cryer / Jamie Richards / Cara Murphy

 

Tel: +44 (0) 203 100 2000

 

 

Peel Hunt (Joint Bookrunner)

Investment Banking

Mike Bell / Ed Allsopp / Ben Harrington

 

Syndicate and Broking

Sohail Akbar / Jock Maxwell Macdonald / John Welch

 

Tel: +44 (0) 20 7418 8900

Redburn (Joint Bookrunner)

Adam Young / Ben Glaeser

Tel: +44 (0) 20 7000 2020

 

 

 

Market Abuse Regulation

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ( EU) No. 596/2014 (as it forms part of UK law by virtue of The European Union (Withdrawal) Act 2018)  ('MAR'). Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

In addition, market soundings (as defined in MAR) were taken in respect of the Placing with the result that certain persons became aware of inside information (as defined in MAR), as permitted by MAR. This inside information is set out in this announcement being made by the Company today. Therefore, those persons that received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

 

PDMR notifications

 

The below notification made in accordance with the requirements of MAR, provides further detail:

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. David Barrett

2. Max Vermorken

3. Garth Palmer

4. Charles Trigg

5. Dean Masefield

2.

Reason for the Notification

a)

Position/status

1. Executive Chairman

2. Chief Executive Officer

3. Chief Finance Officer

4. Non-Executive Director

5. Deputy Chief Finance Officer

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

SigmaRoc plc

b)

LEI

213800Q3CJUERBGD1E44

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p

Identification code

GB00BYX5K988

b)

Nature of the Transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1. 54p

2. 54p

3. 54p

4. 54p

5.  54p

1. 265,741

2. 64,815

3. 55,556

4. 37,037

5.  9,259

 

d)

Aggregated information

Aggregated volume /price

Aggregate volume: 432,408

Aggregate price: 54p

e)

Date of the transaction

23 February 2023

f)

Place of the transaction

London Stock Exchange, AIM



 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFZGZZVFVGFZG

Companies

Sigmaroc (SRC)
UK 100

Latest directors dealings